Comments

Alkermes Stock Price, Quotes and Forecasts

Q: What sector and industry does Alkermes (ALKS) operate in?

Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ALKSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$30.38

At close: May 7, 5:23 PM EDT

$30.20

-0.18-0.59%

After Hours: 5:23 PM EDT

Q1 2025 Earnings were released on Thu May 1st, before the market open

The most recent conference call was at 8:00 AM, 7 days ago Click to view past webcast

Alkermes (ALKS) Forecast

News Earnings Alkermes (ALKS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Alkermes Stock Price, Quotes and Forecasts | NASDAQ:ALKS | Benzinga

Explore Alkermes stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALKS.

Open	-
Close	-
Volume / Avg.	0 / 1.94M
Day Range	- - -
52 Wk Range	22.90 - 36.45
Market Cap	$4.91B
P/E Ratio	14.47
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	11.31%
Days to Cover	6.13

Recent News

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New York.

Piero Cingari

Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

Alkermes Lags Q2 Earnings Estimates

Alkermes (NASDAQ: ALKS) came out with quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.94M
Day Range	- - -
52 Wk Range	22.90 - 36.45
Market Cap	$4.91B
P/E Ratio	14.47
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	11.31%
Days to Cover	6.13

About Alkermes plc

Sector

Health Care

Industry

Biotechnology

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies t...

Got Questions? Ask

What is ALKS's debt-to-equity ratio?

What is ALKS's free cash flow?

What is ALKS's Sharpe ratio?

What is the Pivot support level for ALKS?

What’s driving ALKS's recent performance?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Alkermes (ALKS) stock?

You can purchase shares of Alkermes (NASDAQ:ALKS) through any online brokerage.

View our list of the best stock brokerages

Who are Alkermes (ALKS) competitors?

Other companies in Alkermes’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sarepta Therapeutics (NASDAQ:SRPT) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Alkermes (ALKS) stock?

Alkermes has a consensus price target of $38.20.

What is the current price for Alkermes (ALKS)?

The stock price for Alkermes (NASDAQ: ALKS) is $30.2 last updated May 7, 2025 at 5:23 PM EDT.

Does Alkermes (ALKS) pay a dividend?

There are no upcoming dividends for Alkermes.

When is Alkermes (NASDAQ:ALKS) reporting earnings?

Alkermes’s Q2 earnings are confirmed for Wednesday, July 23, 2025.

Is Alkermes (ALKS) going to split?

There is no upcoming split for Alkermes.

What sector and industry does Alkermes (ALKS) operate in?

Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.